Skip to main content

Table 6 RRT-related Complications of Studies Included in Meta-analysis

From: A comparison of early versus late initiation of renal replacement therapy for acute kidney injury in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials

Outcomes

Study No.

No of patients

Risk Difference (95% CI)

P for Effect

I2

P for Model

hemorrhage

6

1458

0.00(−0.02, 0.01)

0.89

0%

0.73

thrombocytopenia

3

949

0.05(−0.04, 0.14)

0.25

60%

0.08

thrombosis

2

700

−0.01(−0.04, 0.02)

0.40

0%

0.58

hypokalemia

3

924

0.00(−0.08, 0.07)

0.89

61%

0.08

hypophosphatemia

3

924

0.11(−0.09, 0.31)

0.28

92%

<0.0001

hyperkalemia

2

843

−0.01(−0.04, 0.02)

0.41

0%

0.56

RRT-associated arrhythmia

3

920

−0.02(−0.08, 0.04)

0.48

58%

0.09

RRT-associated seizure

3

525

0.00(−0.01, 0.01)

0.85

0%

0.55

hypothermia

2

843

0.01(−0.01, 0.04)

0.28

0%

0.62

catheter infection

4

1014

0.01(−0.02, 0.04)

0.36

31%

0.23

hypotension during RRT

3

652

0.02(−0.02, 0.06)

0.37

37%

0.21

  1. Abbreviations: RRT renal replacement therapy